Endocarditis caused by anaerobic bacteria

Anaerobe

Volumn 47, Issue , 2017, Pages 33-38

  Kestler, M ^a   Munoz P ^a,j   Marin M ^a   Goenaga, M A ^b   Idigoras Viedma P ^b   de Alarcon A ^c   Lepe, J A ^c   Sousa Regueiro, D ^d   Bravo Ferrer, J M ^d   Pajaron M ^e   Costas, C ^f   Garcia Lopez M V ^g   Hidalgo Tenorio, C ^h   Moreno, M ⁱ   Bouza, E ^a,j  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d Osteoarticular and Aging Research Laboratory Hospital Universitario A Coruña   (Spain)

^e HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^f HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

ⁱ HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^j INSTITUTO DE SALUD CARLOS III   (Spain)

more..

Author keywords

Anaerobes; Infective endocarditis; Propionibacterium acnes

Indexed keywords

AMPICILLIN; CEFTRIAXONE; PENICILLIN DERIVATIVE;

ADULT; AGED; ANAEROBIC BACTERIUM; AORTA VALVE PROSTHESIS; ARTICLE; BACTERIAL ENDOCARDITIS; CARDIOVASCULAR MORTALITY; CHARLSON COMORBIDITY INDEX; CLOSTRIDIUM; COHORT ANALYSIS; COMMUNITY ACQUIRED INFECTION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART SURGERY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LACTOBACILLUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MITRAL VALVE PROSTHESIS; NONHUMAN; PROPIONIBACTERIUM ACNES; PROSPECTIVE STUDY; PROSTHESIS INFECTION; SPAIN; TOOTH INFECTION; VERY ELDERLY; YOUNG ADULT; CLASSIFICATION; INCIDENCE; INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; PREVALENCE;

AGED; BACTERIA, ANAEROBIC; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; SPAIN;

EID: 85017315680     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2017.04.002     Document Type: Article

References (31)

1. [1] Brook, I., Infective endocarditis caused by anaerobic bacteria. Arch. Cardiovasc Dis. 101 (2008), 665–676.
2. [2] Felner, J.M., Dowell, V.R. Jr., Anaerobic bacterial endocarditis. N. Engl. J. Med. 283 (1970), 1188–1192.
3. [3] Nastro, L.J., Finegold, S.M., Endocarditis due to anaerobic gram-negative bacilli. Am. J. Med. 54 (1973), 482–496.
4. [4] Murdoch, D.R., Corey, G.R., Hoen, B., Miro, J.M., Fowler, V.G. Jr., Bayer, A.S., et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch. Intern Med. 169 (2009), 463–473.
5. [5] Rodriguez-Sanchez, B., Alcala, L., Marin, M., Ruiz, A., Alonso, E., Bouza, E., Evaluation of MALDI-TOF MS (Matrix-Assisted Laser Desorption-Ionization Time-of-Flight Mass Spectrometry) for routine identification of anaerobic bacteria. Anaerobe 42 (2016), 101–107.
6. [6] Urban E. Five-year retrospective epidemiological survey of anaerobic bacteraemia in a university hospital and rewiew of the literature.
7. [7] Fenner, L., Widmer, A.F., Straub, C., Frei, R., Is the incidence of anaerobic bacteremia decreasing? Analysis of 114,000 blood cultures over a ten-year period. J. Clin. Microbiol. 46 (2008), 2432–2434.
8. [8] Lassmann, B., Gustafson, D.R., Wood, C.M., Rosenblatt, J.E., Reemergence of anaerobic bacteremia. Clin. Infect. Dis. 44 (2007), 895–900.
9. [9] Vena, A., Munoz, P., Alcala, L., Fernandez-Cruz, A., Sanchez, C., Valerio, M., et al. Are incidence and epidemiology of anaerobic bacteremia really changing?. Eur. J. Clin. Microbiol. Infect. Dis. 34 (2015), 1621–1629.
10. [10] Garcia-Granja, P.E., Lopez, J., Vilacosta, I., Ortiz-Bautista, C., Sevilla, T., Olmos, C., et al. Polymicrobial infective endocarditis: clinical features and prognosis. Med. Baltim., 94, 2015, e2000.
11. [11] Baddour, L.M., Infective endocarditis: diagnosis, antimicrobial Therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American heart association: endorsed by the infectious diseases society of America. Circulation 111 (2005), e394–e434.
12. [12] Durack, D.T., Lukes, A.S., Bright, D.K., New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am. J. Med. 96 (1994), 200–209.
13. [13] Mandell, G.L., ELSEVIER, C.L., (eds.) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, seventh ed., 2010, 4320.
14. [14] Goldman, E., Green, L.H., Practical Handbook of Microbiology. second ed., 2008, CRC Press.
15. [15] Nashef, S.A., Roques, F., Hammill, B.G., Peterson, E.D., Michel, P., Grover, F.L., et al. Validation of european Sstem for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur. J. Cardiothorac. Surg. 22 (2002), 101–105.
16. [16] Roques, F., Nashef, S.A., Michel, P., Gauducheau, E., de Vincentiis, C., Baudet, E., et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur. J. Cardiothorac. Surg. 15 (1999), 816–822 discussion 22–3.
17. [17] Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40 (1987), 373–383.
18. [18] Adams, H.P. Jr., Brott, T.G., Crowell, R.M., Furlan, A.J., Gomez, C.R., Grotta, J., et al. Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American heart association. Stroke 25 (1994), 1901–1914.
19. [19] ACC/AHA guidelines for the management of patients with valvular heart disease, A report of the American college of cardiology/American heart association. Task force on practice guidelines (committee on management of patients with valvular heart disease). J. Am. Coll. Cardiol. 32 (1998), 1486–1588.
20. [20] Habib, G., Fau - Lancellotti, P., Lancellotti, P., Fau - Antunes, M.J., Antunes, Mj, Fau - Bongiorni, M.G., Bongiorni, Mg, Fau - Casalta, J.-P., Casalta, Jp, Fau - Del Zotti, F., Del Zotti, F., Fau - Dulgheru, R., et al. ESC guidelines for the management of infective endocarditis: The task force for the management of infective endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur. Heart J. 36:44 (2015 Nov 21), 3075–3128, 10.1093/eurheartj/ehv319 LID - ehv319 [pii].
21. [21] Lombardi, D.P., Engleberg, N.C., Anaerobic bacteremia: incidence, patient characteristics, and clinical significance. Am. J. Med. 92 (1992), 53–60.
22. [22] Ramos, J.M., Garcia-Corbeira, P., Fernandez-Roblas, R., Soriano, F., Bacteremia caused by anaerobes: analysis of 131 episodes. Enferm. Infecc. Microbiol. Clin. 12 (1994), 9–16.
23. [23] Brook, I., Clinical review: bacteremia caused by anaerobic bacteria in children. Crit. Care 6 (2002), 205–211.
24. [24] Finegold, S.M., Bartlett, J.G., Chow, A.W., Flora, D.J., Gorbach, S.L., Harder, E.J., et al. Management of anaerobic infections. Ann. Intern Med. 83 (1975), 375–389.
25. [25] Nord, C.E., Anaerobic bacteria in septicaemia and endocarditis. Scand. J. Infect. Dis. Suppl. 31 (1982), 95–104.
26. [26] Brook, I., The role of anaerobic bacteria in bacteremia. Anaerobe 16 (2010), 183–189.
27. [27] Aubin GG, Portillo ME, Trampuz A, Corvec S. Propionibacterium Acnes, an Emerging Pathogen: from Acne to Implant-infections, from Phylotype to Resistance.
28. [28] Portillo, M.E., Corvec, S., Borens, O., Trampuz, A., Propionibacterium acnes: an underestimated pathogen in implant-associated infections. Biomed. Res. Int., 2013, 2013, 804391.
29. [29] Jorgensen, J.H., Pfaller, M.A., Manual of Clinical Microbiology. 2015, ASM Press.
30. [30] Brouqui, P., Raoult, D., Endocarditis due to rare and fastidious bacteria. Clin. Microbiol. Rev. 14 (2001), 177–207.
31. [31] Thomsen, R.W., Farkas, D.K., Friis, S., Svaerke, C., Ording, A.G., Norgaard, M., et al. Endocarditis and risk of cancer: a Danish nationwide cohort study. Am. J. Med. 126 (2013), 58–67.